ABX-CRO is an independent international CRO, providing standard and specialised phase I–III services, with emphasis on neurosciences, oncology and diagnostic imaging.
With a unique translational medicine approach, we take your product from the appropriate preclinical model, over Phase O microdosing, through to late stage development.
ABX-CRO is based in Dresden, Germany, with global clinical coverage through local and cooperative offices in Australia, Brazil, France, Italy, Hungary, Japan, South Africa, Switzerland, and the US, and a network of home based pharmaceutical research experts. Local CRAs and regulatory expertise ensure fast study set-up and efficient monitoring. Central project management, administration, and quality assurance ensure even data quality and uniform documentation across different cultural environments. Our early phase operations in Germany implement advanced study types, such as oncological, multicentre or pharmacodynamic phase I studies, also for biologicals, radiopharmaceuticals, and HTPs (human tissue derived products). Our specialist radiopharmacy services and the physics department operate centrally from Dresden, Germany.
ABX-CRO advanced pharmaceutical services
Blasewitzer Straße 78-80
D – 01307 Dresden